| Date Filed | Type | Description |
| 06/02/2023 |
4
| Elghandour Rami (See Remarks) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 2,600 shares
@ $44.2688, valued at
$115.1k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/09/2023 |
4
| Elghandour Rami (See Remarks) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 31,442 shares
@ $30.7685, valued at
$967.4k
Exercised 70,211 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Elghandour Rami (See Remarks) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Granted 245,065 options to buy
@ $31.03, valued at
$7.6M
Granted 159,292 restricted stock units
@ $0 |
|
| 09/30/2022 |
4
| Elghandour Rami (See Remarks) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Granted 120,000 options to buy
@ $19.97, valued at
$2.4M
|
|
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2019 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,898 shares
@ $35.52, valued at
$102.9k
|
|
| 11/02/2018 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,368 shares
@ $49.4, valued at
$215.8k
|
|
| 09/19/2018 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Exercised 18,400 options to buy
@ $3.6, valued at
$66.2k
|
|
| 06/05/2018 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 7,894 shares
@ $77.44, valued at
$611.3k
|
|
| 01/05/2018 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 3,019 shares
@ $71.17, valued at
$214.9k
|
|
| 11/16/2017 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 35,250 shares
@ $0
Exercised 70,500 options to buy
@ $76.81, valued at
$5.4M
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 10,000 shares
@ $95.0302, valued at
$950.3k
Exercised 10,000 options to buy
@ $3.6, valued at
$36k
|
|
| 01/05/2017 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 31,044 shares
@ $0
Granted 124,175 options to buy
@ $75.17, valued at
$9.3M
|
|
| 10/12/2016 |
4
| Elghandour Rami (President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 3,000 shares
@ $100, valued at
$300k
Exercised 3,000 options to buy
@ $3.6, valued at
$10.8k
|
|
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| Elghandour Rami (President) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 4,500 shares
@ $60.8282, valued at
$273.7k
Sold 2,500 shares
@ $61.2831, valued at
$153.2k
Exercised 7,000 options to buy
@ $3.6, valued at
$25.2k
|
|
| 03/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |